Back to Search Start Over

Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis

Authors :
Alison E. John
Rebecca H. Graves
K. Tao Pun
Giovanni Vitulli
Ellen J. Forty
Paul F. Mercer
Josie L. Morrell
John W. Barrett
Rebecca F. Rogers
Maryam Hafeji
Lloyd I. Bibby
Elaine Gower
Valerie S. Morrison
Yim Man
James A. Roper
Jeni C. Luckett
Lee A. Borthwick
Ben S. Barksby
Rachel A. Burgoyne
Rory Barnes
Joelle Le
David J. Flint
Susan Pyne
Anthony Habgood
Louise A. Organ
Chitra Joseph
Rochelle C. Edwards-Pritchard
Toby M. Maher
Andrew J. Fisher
Natasja Stæhr Gudmann
Diana J. Leeming
Rachel C. Chambers
Pauline T. Lukey
Richard P. Marshall
Simon J. F. Macdonald
R. Gisli Jenkins
Robert J. Slack
Source :
Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
Publication Year :
2020
Publisher :
Nature Portfolio, 2020.

Abstract

The αvβ6 integrin is key in activating the pro-fibrotic cytokine TGFβ in idiopathic pulmonary fibrosis. Here, the authors show an inhaled small molecule αvβ6 inhibitor GSK3008348 induces prolonged inhibition of TGFβ signaling pathways in human and murine models of lung fibrosis via αvβ6 degradation.

Subjects

Subjects :
Science

Details

Language :
English
ISSN :
20411723
Volume :
11
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Nature Communications
Publication Type :
Academic Journal
Accession number :
edsdoj.0b6e5916f4cb4d2e9b4186f07f1b86ee
Document Type :
article
Full Text :
https://doi.org/10.1038/s41467-020-18397-6